Bupropion Hydrochloride

규격

31677-93-7CAS 번호

250-759-9EC 번호

2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochlorideIUPAC 명칭

C13H19Cl2NO화학식

276.2 g/mol분자량

Bupropion hydrochloride; 31677-93-7; Bupropion Hcl; Amfebutamone hydrochloride; Wellbutrin XL; Wellbutrin SR; Forfivo XL; Mysimba; Budeprion XL; BW 323; DTXSID6044561; ZG7E5POY8O; NSC-315851; BW323; BW-323; DTXCID4024561; NSC315851; CONTRAVE COMPONENT BUPROPION HYDROCHLORIDE; Appbutamone; Forfivo; extended-release; Appbutamone-D; Bupropion XL; Wellbutrin 75; Wellbutrin 100; RefChem:5625; BUPROPION HCL ER; buPROpion HydrochlorideXL; Bupropion Hydrochloride ER; Bupropion Hydrochloride SR; Bupropion Hydrochloride XL; Bupropion HCL ER (XL); BUPROPION HCL ER XL; Bupropion Hydrochloridexl XL; Bupropion Hydrochloride (sr); Bupropion Hydrochloride (xl); BUPROPION HCL ER (SR); Bupropion Hydrochloride SR (sr); BW 323U66; Bupropion Hydrochloride Extended Release; BUPROPION HYDROCHLORIDE, TYROSINE; Bupropion Hydrochloride Extended Release (xl); (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone Hydrochloride; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one hydrochloride; Wellbutrin; Zyban; Budeprion; Wellbatrin; Amfebutamone (Bupropion) HCl; Bupropion SR; 2-(tert-Butylamino)-3'-chloropropiophenone hydrochloride; Bupropion (hydrochloride); Bupropion.HCl; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride; 1-(3-CHLOROPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-1-PROPANONE HYDROCHLORIDE; 234447-17-7; Zyban (pharmaceutical); Voxra; MFCD00055209; (+/-)-Bupropion; Amfebutamon; Amfebutamone; Aplenzin; Bupropion SR; Bupropion XL; 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride (1:1), (-)-; SMR000058423; Budeprion XL 300; Amfebutamon hydrochloride; SR-01000002989; EINECS 250-759-9; UNII-ZG7E5POY8O; NSC 315851; Quomem; 31677-93-7 (HCl); Bupropion hydrochloride [USAN]; Wellbutrin XR; Wellbutrin Retard; Wellbutrin (TN); Prestwick_668; EINECS 252-243-9; Zyban (TN); m-Chloro-alpha-tert-butylaminopropiophenone hydrochloride; alpha-(tert-Butylamino)-m-chloropropiophenone hydrochloride; m-Chloro-alpha-tert-butylaminopropionphenone hydrochloride; Bupropion hydrochloride [USAN:USP:JAN]; (+-)-2-(tert-Butylamino)-3'-chloropropiophenone hydrochloride; (+-)-alpha-tert-Butylamino-3-chloropropiophenone hydrochloride; Amfebutamone (Bupropion); NCGC00016807-01; CAS-31677-93-7; CHEMBL1698; SCHEMBL41602; 34841-36-6; MLS000069376; MLS001401370; MLS002320678; SPECTRUM1504174; CHEBI:3220; orb1225322; SCHEMBL29420039; HY-B0403A; BVF 033; BW 322U; CPI-300; GLXC-07735; HMS1568B20; HMS1922F09; HMS5081I05; Pharmakon1600-01504174; Bupropion HCl - Bio-X trade mark; Bupropion hydrochloride (JAN/USP); MSK10349; BUPROPION HYDROCHLORIDE [MI]; Tox21_110621; Tox21_301844; Tox21_500166; AC-196; BUPROPION HYDROCHLORIDE [JAN]; BW-323U66; CCG-39085; EBC-03692; NSC758686; Propiophenone, 2-(tert-butylamino)-3'-chloro-, hydrochloride, (+-)-; BUPROPION HYDROCHLORIDE [HSDB]; AKOS015844544; Tox21_110621_1; AB02273; BUPROPION HYDROCHLORIDE [MART.]; BUPROPION HYDROCHLORIDE [VANDF]; CCG-100911; FB61552; KS-1034; LP00166; NC00161; (+/-)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride; 1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, hydrochloride, (+-)-; BUPROPION HYDROCHLORIDE [USP-RS]; BUPROPION HYDROCHLORIDE [WHO-DD]; NCGC00015122-11; NCGC00093650-01; NCGC00093650-02; NCGC00093650-03; NCGC00093650-04; NCGC00093650-05; NCGC00180895-01; NCGC00180895-02; NCGC00255927-01; NCGC00260851-01; Propiophenone, hydrochloride, (.+-.)-; BB164268; SMR001338824; B-102; B3649; B8363; BUPROPION HYDROCHLORIDE [ORANGE BOOK]; EU-0100166; NS00088186; S2452; SW196823-6; BUPROPION HYDROCHLORIDE [USP IMPURITY]; BUPROPION HYDROCHLORIDE [USP MONOGRAPH]; D00817; AUVELITY COMPONENT BUPROPION HYDROCHLORIDE; Bupropion hydrochloride, >=98% (HPLC), solid; EN300-1707780; Bupropion.HCl, 1mg/ml in Methanol (as free base); Bupropion hydrochloride 100 |Ig/mL in Acetonitrile; SR-01000002989-2; 2-(t-Butylamino)-3'-chloropropiophenone hydrochloride; Bupropion hydrochloride 100 microg/mL in Acetonitrile; Q27295463; SR-01000002989-10; Z1741979718; (+/-)-2-(t-butylamino)-3'-chloropropiophenone hydrochloride; 1-Propanone,1-dimethylethyl)amino]-, hydrochloride, (.+-.)-; Bupropion Hydrochloride 1.0 mg/ml in Methanol (as free base); (+/-)-2-(tert-butylamino)-3'-chloropropiophenone hydrochloride; (.+-.)-2-(tert-Butylamino)-3'-chloropropiophenone hydrochloride; 2-(tert-Butylamino)-1-(3-chlorophenyl)-1-propanone Hydrochloride; Bupropion.HCl, 1mg/ml in Acetonitrile/Water : 1/1 (as free base); Bupropion hydrochloride, United States Pharmacopeia (USP) Reference Standard; 1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone, hydrochloride; 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride (1:1); Bupropion Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; ( inverted question mark)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride; 1-PROPANONE, 1-(3-CHLOROPHENYL)-2-((1,1-DIMETHYLETHYL)AMINO)-, HYDROCHLORIDE, (+/-)-동의어